CLINICAL_TRIALS
trial_result
· 2017-07-02
Clinical Trial Update: Effects of Long-Term Treatment With Valaciclovir (Valtrex) on Epstein-Barr Virus
Summary
This completed trial evaluated the effects of long-term valacyclovir (Valtrex) treatment on Epstein-Barr virus activity. The study included participants with EB…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Epstein Barr Virus Infection, Healthy | Status: COMPLETED